The growth of the global cell expansion market is primarily driven by the growing prevalence of chronic diseases and increasing investments offered by the governments to fuel cell based research. The growth of the global market is also being driven by increasing focus on customized and personalized medicine. Additionally, rising onus on the research and development activities on the cell based therapies and rising GMP certifications for production facilities for cell therapy are also important for driving the growth of the global cell expansion market.
The competitive landscape of the global cell expansion market is fairly consolidated in nature. The companies in the global market are eyeing to get at the top of the pyramid with the help of advanced research and development activities. Naturally, the companies are investing heavily in such R&D activities and are coming up with new cell applications and cell lines. These companies are also concentrating on product differentiation in order to strengthen their overall market position. Naturally, such developments are expected to drive the development of the market and further intensify the competition. The companies in the global cell expansion market are also expected to resort to aggressive growth strategies such as mergers, takeovers, acquisitions, strategic partnerships and alliances in order to stay ahead of their competitive rivals.
Some of the key developments in the global cell expansion market are given below:
- In 2016, Thermo Fisher Scientific Inc. announced that the company has acquired Affyetrix Inc. a US based company. Thermo Fisher announced that the company invested US$1.3 billion for this deal. This takeover helps the company to improve their product portfolio in the field of genetic and cellular analysis.
- In 2017, Becton Dickenson and Company announced that they have received a 501(k) clearance for its BD FACSLyric flow cytometer system.
Global Cell Expansion Market: Snapshot
The global cell expansion market is fairly consolidated with the top eight players accounting for most of the market share. Majority of the top players, with an aim of furthering their market share, are expending a lot of money and time on research and development in order to come up with new cell lines and applications. They are also focusing hard on product differentiation to bolster their positions. On account of this, competition is robust in the market for cell expansion.
Providing tailwinds to the global cell expansion market is the growing prevalence of rare and chronic conditions and also the continued rise in demand for biopharmaceuticals. Growing demand for regenerative medicines that provide faster results and cell-based therapies that have high patient compatibility are also said to be stoking market growth.
High cost involved in operations due to the need for skilled workforce and high tech instrumentation, however, is acting as a deterrent for the market. Strict rules and regulations pertaining to cell expansion processes owing to the ethical concerns surrounding it too is crimping market growth to an extent.
However, despite all obstacles, the market will likely clock a robust CAGR of 14.7% between 2016 and 2024, finds a report by Transparency Market Research. Growing at this pace, the report predicts the market to attain a value of US$26 bn by 2024-end from US$7.737 bn in 2015.
Increase in Chronic Diseases Propels Market for Human Stem Cells
The global cell expansion market can be broadly divided into human stem cells, human differentiated cells, and animal cells based on the types of cells. Of them, the human stem cell segment accounts for a leading share in the market vis-à-vis revenue due of the increasing instances of various chronic diseases and support provided by the government. In 2016, it held a substantial 58.1% share in the overall revenue in the global cell expansion market.
The animal cell segment, on the other hand, is also predicted to grow at an impressive 14.6% CAGR from 2016 to 2024 to become worth US$ 7,432.6 Mn by 2024 on the back of demand for development of vaccines against some parasitic and viral diseases.
North America Market Shines due to Presence of Key Players in the Region
Geographically, the global cell expansion market can be segmented into Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. North America, of them, is the leading market. In 2016, it held a 39.3% share in the market. The regions dominant share is the result of a large number of prominent players domiciled there and the increasing spends on research and development in the area. In the years ahead, North America is predicted to trim its market share and by 2024 it is slated to hold 37.7% share. It will still retain its leading share, however by rising at a 14.7% CAGR during the period from 2016 to 2024.
In terms of growth rate, Asia Pacific will expected to outpace all other regions by clock a stellar CAGR of 16.4% between 2016 and 2024. This is because of the key players keen on tapping into the opportunities in the emerging economies in the region such as India and China. Besides, growing number of market participants from the nations of Japan, Australia, India, and China is also majorly filliping the cell expansion market in Asia Pacific. The trend of outsourcing research processes to low cost destinations in Asia Pacific and the availability of expertise in the region has also been stoking growth.
Global Cell Expansion Market: Overview
This report on the global cell expansion market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases.
The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global Cell Expansion market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cell expansion market.
Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increase in prevalence of cancer and rare diseases, rise in demand for regenerative and cell-based therapies and historical year-on-year growth have been taken into consideration while estimating the market size.
Global Cell Expansion Market: Segmentation
The cell expansion market has segmented into four categories, namely by type of cells, by product, by end-user and by region.
Geographically, the global Cell Expansion market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.
Global Cell Expansion Market: Competitive Landscape
The report also profiles major players in the cell expansion market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include GE Healthcare, Danaher Corporation (Pall Corporation), Terumo Corporation, Merck Millipore (Merck KGaA), Octane Biotech, Inc., Thermo Fisher Scientific, Inc., Lonza Group, STEMCELL Technologies, Inc., Becton, Dickinson and Company, Bio-Techne (R&D Systems), Takara Bio, Inc., Cell Signaling Technology, Inc., PeproTech, CellGenix GmbH, Corning Incorporated, Eppendorf AG, and HiMedia Laboratories.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
The global cell expansion market is segmented as follows:
|
by Type of Cells |
|
|
by Product Type |
|
|
by End User |
|
|
by Geography |
|
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Section - 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section - 2 Assumptions and Research Methodology
2.1 Assumptions and Acronyms Used
2.2 Research Methodology
Section-3 Executive Summary
3.1 Global Cell Expansion: Market Snapshot
3.2 Global Cell Expansion Market: Opportunity Map
Section-4 Market Overview
4.1 Global Cell Expansion Market: Key Industry Developments
Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.1.2 Drivers
5.1.2.1 Rise in demand for regenerative and cell-based therapies
5.1.2.2 High demand for biopharmaceuticals
5.1.2.3 Increase in investment by public and private organizations
5.1.2.4 Rise in Research and Development Activities
5.1.2.5 Increase in prevalence of cancer and rare diseases
5.1.3 Restraints
5.1.3.1 High cost of operations and maintenance of cell expansion system
5.1.3.2 Ethical issues in human cell expansion
5.1.3.3 Stringent laws and regulations pertaining to cell expansion products and applications
5.1.4 Opportunity Analysis
5.1.4.1 Discovery of New Human Cell Based Therapies
5.1.4.2 Use of Cell Expansion in Drug Screening and Testing
5.3 Key Trends
5.4 Porter’s Five Forces Analysis
5.5 Global Cell Expansion Market Revenue Projection
5.6 Cell Expansion Market Outlook
5.7 Cell Expansion Market: Value Chain Analysis
5.8 Regulatory Status for Cell Expansion Systems
5.9 FDA Approvals
Section-6 Cell Expansion Market Analysis By Type of Cell
6.1 Key Findings
6.2 Introduction
6.3 Global Cell Expansion Market Value Share Analysis, By Type of Cell
6.4 Global Cell Expansion Market Forecast By Type of Cell
6.4.1 Human Cells
6.4.1.1 Stem Cells
6.4.1.1.1 Adult Stem Cells
6.4.1.1.1.1 Tissue-specific stem cells (Natural Killer cells, T-cells, etc.)
6.4.1.1.1.2 Mesenchymal stem cells (MSCs)
6.4.1.1.2 Induced Pluripotent Stem Cells
6.4.1.1.3 Embryonic Stem Cells
6.4.1.2 Differentiated Cells
6.4.2 Animal Cells
6.5 Global Cell Expansion Market Attractiveness Analysis By Type of Cell
6.6 Key Insights
Section-7 Cell Expansion Market Analysis By Product
7.1 Key Findings
7.2 Introduction
7.3 Global Cell Expansion Market Value Share Analysis, By Product
7.4 Global Cell Expansion Market Forecast By Product
7.4.1 Instruments
7.4.1.1 Cell Expansion Supporting Equipment
7.4.1.1.1 Centrifuges
7.4.1.1.2 Flow Cytometers
7.4.1.1.3 Filtration Systems
7.4.1.1.4 Microscopes
7.4.1.1.5 Incubators
7.4.1.1.6 Laminar Air Flow Cabinets
7.4.1.1.7 Others
7.4.1.2 Bioreactors
7.4.1.2.1 Micro Carrier-based Anchorage Dependent Bioreactors
7.4.1.2.2 Suspension-based Anchorage Independent Bioreactors
7.4.1.2.3 Perfusion/Hollow Fiber Bioreactors
7.4.1.3 Automated Cell Expansion Systems
7.4.2 Consumables
7.4.2.1 Reagents
7.4.2.2 Media
7.4.2.3 Sera
7.4.3 Disposables
7.4.3.1 Bioreactor Accessories
7.4.3.2 Tissue Culture Flasks
7.4.3.3 Others
7.5 Global Cell Expansion Market Attractiveness Analysis By Product
7.6 Key Insights
Section-8 Global Cell Expansion Market Analysis By End User
8.1 Key Findings
8.2 Introduction
8.3 Global Cell Expansion Market Value Share Analysis, By End User
8.4 Global Cell Expansion Market Forecast By End User
8.4.1 Hospitals
8.4.2 Contract Manufacturing Organization & Contract Research Organization
8.4.3 Biotechnology & Pharmaceutical Companies
8.4.4 Academic & Research Institutes
8.5 Global Cell Expansion Market Attractiveness Analysis By End User
Section-9 Global Cell Expansion Market Analysis, By Region
9.1 Global Market Scenario
9.2 Global Cell Expansion Market Value Share Analysis, By Region
9.2.1 Global Cell Expansion Market Forecast By Region
9.3 Global Cell Expansion Market Attractiveness Analysis, By Region
9.4 Global Cell Expansion Market Regional Trends
Section-10 North America Cell Expansion Market Analysis
10.1 North America Market Value Share Analysis, By Country
10.1.1 North America Market Forecast By Country
10.2 North America Market Forecast By Type of Cells
10.3 North America Market Forecast By Product
10.4 North America Market Forecast By End User
10.5 North America Market Attractiveness Analysis
Section-11 Europe Cell Expansion Market Analysis
11.1 Europe Market Value Share Analysis, By Country
11.1.1 Europe Market Forecast By Country
11.2 Europe Market Forecast By Type of Cells
11.3 Europe Market Forecast By Product
11.4 Europe Market Forecast By End User
11.5 Europe Market Attractiveness Analysis
Section-12 Asia Pacific Cell Expansion Market Analysis
12.1 Asia Pacific Market Value Share Analysis, By Country
12.1.1 Asia Pacific Market Forecast By Country
12.2 Asia Pacific Market Forecast By Type of Cells
12.3 Asia Pacific Market Forecast By Product
12.4 Asia Pacific Market Forecast By End User
12.5 Asia Pacific Market Attractiveness Analysis
Section-13 Latin America Cell Expansion Market Analysis
13.1 Latin America Market Value Share Analysis, By Country
13.1.1 Latin America Market Forecast By Country
13.2 Latin America Market Forecast By Type of Cells
13.3 Latin America Market Forecast By Product
13.4 Latin America Market Forecast By End User
13.5 Latin America Market Attractiveness Analysis
Section-14 Middle East and Africa Cell Expansion Market Analysis
14.1 Middle East and Africa Market Value Share Analysis, By Country
14.1.1 Middle East and Africa Market Forecast By Country
14.2 Middle East and Africa Market Forecast By Type of Cells
14.3 Middle East and Africa Market Forecast By Product
14.4 Middle East and Africa Market Forecast By End User
14.5 Middle East and Africa Market Attractiveness Analysis
Section-15 Competition Landscape
15.1 Global Cell Expansion Market Share Analysis, by Company
15.2 Competition Matrix
15.3 Company Profiles
15.3.1 CellGenix GmbH
15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2 Financial Overview
15.3.1.3 Product Portfolio
15.3.1.4 SWOT Analysis
15.3.1.5 Strategic Overview
15.3.2 Corning, Inc.
15.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2 Financial Overview
15.3.2.3 Product Portfolio
15.3.2.4 SWOT Analysis
15.3.2.5 Strategic Overview
15.3.3 Eppendorf AG
15.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2 Financial Overview
15.3.3.3 Product Portfolio
15.3.3.4 SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4 HiMedia Laboratories
15.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2 Financial Overview
15.3.4.3 Product Portfolio
15.3.4.4 SWOT Analysis
15.3.4.5 Strategic Overview
15.3.5 GE Healthcare
15.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2 Financial Overview
15.3.5.3 Product Portfolio
15.3.5.4 SWOT Analysis
15.3.5.5 Strategic Overview
15.3.6 Danaher Corporation (Pall Corporation)
15.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2 Financial Overview
15.3.6.3 Product Portfolio
15.3.6.4 SWOT Analysis
15.3.6.5 Strategic Overview
15.3.7 Terumo Corporation
15.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2 Financial Overview
15.3.7.3 Product Portfolio
15.3.7.4 SWOT Analysis
15.3.7.5 Strategic Overview
15.3.8 Merck Millipore (Merck KGaA )
15.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2 Financial Overview
15.3.8.3 Product Portfolio
15.3.8.4 SWOT Analysis
15.3.8.5 Strategic Overview
15.3.9 Miltenyi Biotec
15.3.9.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2 Financial Overview
15.3.9.3 Product Portfolio
15.3.9.4 SWOT Analysis
15.3.9.5 Strategic Overview
15.3.10 Octane Biotech, Inc.
15.3.10.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2 Financial Overview
15.3.10.3 Product Portfolio
15.3.10.4 SWOT Analysis
15.3.10.5 Strategic Overview
15.3.11 Thermo Fisher Scientific, Inc.
15.3.11.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2 Financial Overview
15.3.11.3 Product Portfolio
15.3.11.4 SWOT Analysis
15.3.11.5 Strategic Overview
15.3.12 Lonza Group
15.3.12.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2 Financial Overview
15.3.12.3 Product Portfolio
15.3.12.4 SWOT Analysis
15.3.12.5 Strategic Overview
15.3.13 STEMCELL Technologies, Inc.
15.3.13.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2 Financial Overview
15.3.13.3 Product Portfolio
15.3.13.4 SWOT Analysis
15.3.13.5 Strategic Overview
15.3.14 Becton, Dickinson and Company
15.3.14.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.14.2 Financial Overview
15.3.14.3 Product Portfolio
15.3.14.4 SWOT Analysis
15.3.14.5 Strategic Overview
15.3.15 Bio-Techne (R&D Systems)
15.3.15.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.15.2 Financial Overview
15.3.15.3 Product Portfolio
15.3.15.4 SWOT Analysis
15.3.15.5 Strategic Overview
15.3.16 Takara Bio, Inc.
15.3.16.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.16.2 Financial Overview
15.3.16.3 Product Portfolio
15.3.16.4 SWOT Analysis
15.3.16.5 Strategic Overview
15.3.17 Cell Signaling Technology, Inc.
15.3.17.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.17.2 Financial Overview
15.3.17.3 Product Portfolio
15.3.17.4 SWOT Analysis
15.3.17.5 Strategic Overview
15.3.18 PeproTech
15.3.18.1 Company Overview (HQ, Business Segments, Employee Strength)
15.3.18.2 Financial Overview
15.3.18.3 Product Portfolio
15.3.18.4 SWOT Analysis
15.3.18.5 Strategic Overview
List of Tables
Table 1: Global Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell, 2014–2024
Table 2: Global Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Human Cells), 2014–2024
Table 3: Global Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Stem Cells), 2014–2024
Table 4: Global Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Adult Stem Cells), 2014–2024
Table 5: Global Cell Expansion Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 6: Global Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments), 2014–2024
Table 7: Global Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments – Cell Expansion Supporting Equipment), 2014–2024
Table 8: Global Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments – Bioreactors), 2014–2024
Table 9: Global Cell Expansion Market Size (US$ Mn) Forecast, by Product (Consumables), 2014–2024
Table 10: Global Cell Expansion Market Size (US$ Mn) Forecast, by Product (Disposables), 2014–2024
Table 11: Global Cell Expansion Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 12: Global Cell Expansion Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 13: North America Cell Expansion Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 14: North America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell, 2014–2024
Table 15: North America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Human Cells), 2014–2024
Table 16: North America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Stem Cells), 2014–2024
Table 17: North America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Adult Stem Cells), 2014–2024
Table 18: North America Cell Expansion Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 19: North America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments), 2014–2024
Table 20: North America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments - Cell Expansion Supporting Equipment), 2014–2024
Table 21: North America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments- Bioreactors), 2014–2024
Table 22: North America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Consumables), 2014–2024
Table 23: North America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Disposables), 2014–2024
Table 24: North America Cell Expansion Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 25: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 26: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell, 2014–2024
Table 27: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Type of Human Cells, 2014–2024
Table 28: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Stem Cells), 2014–2024
Table 29: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Adult Stem Cells), 2014–2024
Table 30: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 31: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments), 2014–2024
Table 32: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments - Cell Expansion Supporting Equipment), 2014–2024
Table 33: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments - Bioreactors), 2014–2024
Table 34: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Product (Consumables), 2014–2024
Table 35: Europe Cell Expansion Market Size (US$ Mn) Forecast, by Product (Disposables), 2014–2024
Table 36: Europe Cell Expansion Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 37: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 38: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell, 2014–2024
Table 39: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Human Cells), 2014–2024
Table 40: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Stem Cells), 2014–2024
Table 41: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Adult Stem Cells), 2014–2024
Table 42: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 43: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments), 2014–2024
Table 44: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments - Cell Expansion Supporting Equipment), 2014–2024
Table 45: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments - Bioreactors), 2014–2024
Table 46: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Product (Consumables), 2014–2024
Table 47: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by Product (Disposables), 2014–2024
Table 48: Asia Pacific Cell Expansion Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 49: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 50: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell, 2014–2024
Table 51: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Human Cells, 2014–2024
Table 52: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Stem Cells), 2014–2024
Table 53: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Adult Stem Cells), 2014–2024
Table 54: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 55: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments), 2014–2024
Table 56: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments - Cell Expansion Supporting Equipment), 2014–2024
Table 57: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments- Bioreactors), 2014–2024
Table 58: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Consumables), 2014–2024
Table 59: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by Product (Disposables), 2014–2024
Table 60: Latin America Cell Expansion Market Size (US$ Mn) Forecast, by End-user, 2014–2024
Table 61: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 62: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell, 2014–2024
Table 63: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Human Cells), 2014–2024
Table 64: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Stem Cells), 2014–2024
Table 65: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Type of Cell (Adult Stem Cells), 2014–2024
Table 66: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Product, 2014–2024
Table 67: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments), 2014–2024
Table 68: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments - Cell Expansion Supporting Equipment), 2014–2024
Table 69: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Product (Instruments- Bioreactors), 2014–2024
Table 70: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Product (Consumables), 2014–2024
Table 71: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by Product (Disposables), 2014–2024
Table 72: Middle East & Africa Cell Expansion Market Size (US$ Mn) Forecast, by End-user, 2014–2024
List of Figures
Figure 1: Global Cell Expansion Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Market Value Share, by Type of Cell (2016)
Figure 3: Market Value Share, by Product (2016)
Figure 4: Market Value Share, by End-user (2016)
Figure 5: Market Value Share, by Region (2016)
Figure 6: Global Cell Expansion Market Value Share Analysis, by Type of Cell, 2016 and 2024
Figure 7: Global Cell Expansion Market Attractiveness Analysis, by Type of Cell, 2016–2024
Figure 8: Global Human Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 9: Global Animal Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: Global Differentiated Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 12: Global Adult Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 13: Global Induced Pluripotent Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 14: Global Embryonic Stem Cells Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 15: Global Cell Expansion Market Value Share Analysis, by Product, 2016 and 2024
Figure 16: Global Cell Expansion Market Attractiveness Analysis, by Product, 2016–2024
Figure 17: Global Cell Expansion Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2014–2024
Figure 18: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 19: Global Cell Expansion Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disposables, 2014–2024
Figure 20: Global Cell Expansion Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cell Expansion Supporting Equipment, 2014–2024
Figure 21: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 22: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 23: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 24: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 25: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 26: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 27: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 28: Global Cell Expansion Market Revenue (US$ Mn) and
Figure 29: Global Cell Expansion Market Value Share Analysis, by End-user, 2016 and 2024
Figure 30: Global Cell Expansion Market Attractiveness Analysis, by End-user, 2016–2024
Figure 31: Global Hospitals Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 32: Global CMO & CRO Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 33: Global Biotechnology & Pharmaceutical Companies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 34: Global Academic & Research Institutes Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 35: Global Cell Expansion Market Value Share Analysis, by Region, 2016 and 2024
Figure 36: Global Cell Expansion Market Attractiveness Analysis, by Region, 2016–2024
Figure 37: North America Cell Expansion Market Value Share Analysis, by Country, 2016 and 2024
Figure 38: North America Cell Expansion Market Attractiveness Analysis, by Country, 2016–2024
Figure 39: North America Market Attractiveness Analysis, by Type of Cell, 2016–2024
Figure 40: North America Market Attractiveness Analysis, by Product, 2016–2024
Figure 41: North America Market Attractiveness Analysis by End-user, 2016–2024
Figure 42: Europe Cell Expansion Market Value Share Analysis, by Country, 2016 and 2024
Figure 43: Europe Cell Expansion Market Attractiveness Analysis, by Country, 2016–2024
Figure 44: Europe Market Attractiveness Analysis, by Type of Cell, 2016–2024
Figure 45: Europe Market Attractiveness Analysis, by Product, 2016–2024
Figure 46: Europe Market Attractiveness Analysis, by End-user, 2016–2024
Figure 47: Asia Pacific Cell Expansion Market Value Share Analysis, by Country, 2016 and 2024
Figure 48: Asia Pacific Cell Expansion Market Attractiveness Analysis, by Country, 2016–2024
Figure 49: Asia Pacific Market Attractiveness Analysis, by Type of Cell, 2016–2024
Figure 50: Asia Pacific Market Attractiveness Analysis, by Product, 2016–2024
Figure 51: Asia Pacific Market Attractiveness Analysis, by End-user, 2016–2024
Figure 52: Latin America Cell Expansion Market Value Share Analysis, by Country, 2016 and 2024
Figure 53: Latin America Cell Expansion Market Attractiveness Analysis, by Country, 2016–2024
Figure 54: Latin America Market Attractiveness Analysis, by Type of Cell, 2016–2024
Figure 55: Latin America Market Attractiveness Analysis, by Product, 2016–2024
Figure 56: Latin America Market Attractiveness Analysis, by End-user, 2016–2024
Figure 57: Middle East & Africa Cell Expansion Market Value Share Analysis, by Country, 2016 and 2024
Figure 58: Middle East & Africa Cell Expansion Market Attractiveness Analysis, by Country, 2016–2024
Figure 59: Middle East & Africa Market Attractiveness Analysis, by Type of Cell, 2016–2024
Figure 60: Middle East & Africa Market Attractiveness Analysis, by Product, 2016–2024
Figure 61: Middle East & Africa Market Attractiveness Analysis, by End-user, 2016–2024
Figure 62: Global Cell Expansion Market Share Analysis, by Company (2016)
